Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan · Delayed Price · Currency is TWD 54.00
-0.60 (-1.10%)
At close: May 29, 2026
Pet Pharm Biotech Market Cap
Pet Pharm Biotech has a market cap or net worth of 3.09 billion as of May 29, 2026. Its market cap has increased by 8.45% in one year.
Market Cap
3.09B
Enterprise Value
2.70B
Revenue
222.03M
Ranking
n/a
PE Ratio
117.39
Stock Price
54.00
Market Cap Chart
Since July 26, 2024, Pet Pharm Biotech's market cap has increased from 1.39B to 3.09B, an increase of 122.00%. That is a compound annual growth rate of 54.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 3.09B | -13.78% |
| Dec 31, 2025 | 3.58B | 116.51% |
| Dec 31, 2024 | 1.66B | 18.92% |
| Jul 26, 2024 | 1.39B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HanchorBio | 17.81B |
| Elixiron Immunotherapeutics (Cayman) Limited | 9.44B |
| Uwell Biopharma | 7.99B |
| Intelligene | 6.76B |
| Obigen Pharma | 3.97B |
| BIONET Therapeutics | 2.66B |
| FullHope Biomedical | 1.23B |
| Genomics BioSci & Tech. | 1.20B |